Patent Assignment
Reel/Frame 044020/0068
Assignment of Assignor's Interest
Recorded: 2017-11-02
Pages: 6
Assignor
VTVX HOLDINGS II LLC
Executed: 2015-07-29
Assignee
VTV THERAPEUTICS LLC
4170 MENDENHALL OAKS PARKWAY, HIGH POINT, NORTH CAROLINA, 27265
Covered Property
(1)
Tricyclic Compounds as Modulators of Tnf-Alpha Synthesis and as PDE4 Inhibitors
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Change of Name
Nov 2, 2017
From: HIGH POINT PHARMACEUTICS, LLC
To: VTVX HOLDINGS II LLC
Reel/Frame 044680/0742 →
Assignment of Assignor's Interest
Nov 2, 2017
From: MJALLI, ADNAN M.M.; GADDAM, BAPU; POLISETTI, DHARMA RAO; KOSTURA, MATTHEW J.
To: TRANSTECH PHARMA, INC.
Reel/Frame 044020/0001 →
Assignment of Assignor's Interest
Nov 2, 2017
From: TRANSTECH PHARMA, INC.
To: HIGH POINT PHARMACEUTICS, LLC
Reel/Frame 044020/0026 →
Security Interest
Apr 18, 2018
From: VTV THERAPEUTICS LLC
To: HORIZON TECHNOLOGY FINANCE CORPORATION, AS COLLATERAL AGENT
Reel/Frame 045969/0774 →
Release of Security Interest
Jan 27, 2021
From: HORIZON TECHNOLOGY FINANCE CORPORATION, AS COLLATERAL AGENT
To: VTV THERAPEUTICS LLC
Reel/Frame 055133/0214 →